MODERATOR
:
SPEAKER
(S):
Patricia Arndt, MS, MT(ASCP)SBB, Sr. Research Associate, American Red Cross Blood Services
Mechanisms and Laboratory Investigation of Drug-Induced Immune Hemolytic Anemia
George Garratty, PhD, FRCPath, Scientific Director, American Red Cross Blood Services
Description
Drug-induced hemolytic anemia (DIHA) should be considered whenever any hemolytic anemia is suspected. A vast number of common drugs can cause a positive direct antiglobuin test (DAT) and in some patients this will be associated with significant hemolysis. This session will review correlation of patient history and laboratory data that is essential for the diagnosis of DIHA.
-
Assess the serologic findings associated with drug-induced hemolytic anemia.
-
Describe the different mechanisms of drug-induced hemolysis.
-
Identify drugs commonly associated with immune hemolysis.
-
List laboratory tests useful for making the diagnosis of drug-induced hemolytic anemia.
| CE Category | CE Value |
|---|
|
California Clinical Laboratory Personnel |
1.5 |
|
California Nurse |
1.8 |
|
Florida Laboratory Personnel |
1.8 |
|
General Attendee |
1.5 |
|
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.